DE2254061A1 - Lh-releasing hormon zur nasalen applikation - Google Patents

Lh-releasing hormon zur nasalen applikation

Info

Publication number
DE2254061A1
DE2254061A1 DE2254061A DE2254061A DE2254061A1 DE 2254061 A1 DE2254061 A1 DE 2254061A1 DE 2254061 A DE2254061 A DE 2254061A DE 2254061 A DE2254061 A DE 2254061A DE 2254061 A1 DE2254061 A1 DE 2254061A1
Authority
DE
Germany
Prior art keywords
preservative
hlb value
value below
active ingredient
soft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2254061A
Other languages
German (de)
English (en)
Inventor
Erich Ebel
Rolf Dipl Chem Dr Geiger
Wolfgang Dipl Chem Dr Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE2254061A priority Critical patent/DE2254061A1/de
Priority to NL7314883A priority patent/NL7314883A/xx
Priority to AT925173A priority patent/AT330962B/de
Priority to CA184,949A priority patent/CA1014471A/en
Priority to ZA738460A priority patent/ZA738460B/xx
Priority to AU62159/73A priority patent/AU485185B2/en
Priority to GB5132473A priority patent/GB1454105A/en
Priority to FR7339235A priority patent/FR2205307A1/fr
Priority to BE137403A priority patent/BE806912A/xx
Publication of DE2254061A1 publication Critical patent/DE2254061A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2254061A 1972-11-04 1972-11-04 Lh-releasing hormon zur nasalen applikation Pending DE2254061A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE2254061A DE2254061A1 (de) 1972-11-04 1972-11-04 Lh-releasing hormon zur nasalen applikation
NL7314883A NL7314883A (xx) 1972-11-04 1973-10-30
AT925173A AT330962B (de) 1972-11-04 1973-11-02 Verfahren zur herstellung eines praparates zur nasalen applikation
CA184,949A CA1014471A (en) 1972-11-04 1973-11-02 Lh-releasing hormone for nasal application
ZA738460A ZA738460B (en) 1972-11-04 1973-11-02 Lh-releasing hormone for nasal application
AU62159/73A AU485185B2 (en) 1972-11-04 1973-11-05 Lh-releasing hormone for nasal application
GB5132473A GB1454105A (en) 1972-11-04 1973-11-05 Preparation containing luteinizing hormone-releasing factor
FR7339235A FR2205307A1 (en) 1972-11-04 1973-11-05 Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.
BE137403A BE806912A (fr) 1972-11-04 1973-11-05 Composition therapeutique a base d'hormone liberant l'hormone luteinisante pour application par voie nasale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2254061A DE2254061A1 (de) 1972-11-04 1972-11-04 Lh-releasing hormon zur nasalen applikation

Publications (1)

Publication Number Publication Date
DE2254061A1 true DE2254061A1 (de) 1974-05-16

Family

ID=5860838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2254061A Pending DE2254061A1 (de) 1972-11-04 1972-11-04 Lh-releasing hormon zur nasalen applikation

Country Status (7)

Country Link
AT (1) AT330962B (xx)
BE (1) BE806912A (xx)
CA (1) CA1014471A (xx)
DE (1) DE2254061A1 (xx)
FR (1) FR2205307A1 (xx)
NL (1) NL7314883A (xx)
ZA (1) ZA738460B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115627A1 (en) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Enhancement of intranasal absorption of calcitonin by formulation with surfactants

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115627A1 (en) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Enhancement of intranasal absorption of calcitonin by formulation with surfactants

Also Published As

Publication number Publication date
AT330962B (de) 1976-07-26
AU6215973A (en) 1975-05-08
FR2205307B1 (xx) 1977-09-09
FR2205307A1 (en) 1974-05-31
BE806912A (fr) 1974-05-06
ZA738460B (en) 1974-10-30
NL7314883A (xx) 1974-05-07
CA1014471A (en) 1977-07-26
ATA925173A (de) 1975-10-15

Similar Documents

Publication Publication Date Title
DE4332436B4 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzungen
DE2827018C2 (xx)
AT390372B (de) Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung
CA2365536C (en) Compositions and methods for improved delivery of hydrophobic therapeutic agents
DE69932158T2 (de) Pharmazeutische zusammenstellungen
DE69634666T2 (de) Lipid-extrakte mit entzündungshemmender aktivität
US4486448A (en) Copper lanolate and anti-acne compositions containing the same for topical application to the skin
EP0252286A2 (de) Neue pharmazeutische Präparate zur topischen Applikation, Verfahren zu ihrer Herstellung und ihre Verwendung
DD159736A5 (de) Verfahren zur herstellung eines pharmazeutischen steroidpraeparates
DE2629100A1 (de) Liposomdispersionen und verfahren zu deren herstellung
EP0711557A1 (de) Pharmazeutische Formulierungsgrundlage
DE1467907C3 (de) Verfahren zur Herstellung von .Weich gelatinekapseln
DE3913954A1 (de) Arzneimittel zur behandlung erektiler dysfunktionen
DE3705894A1 (de) Pharmazeutische zusammensetzungen
CH634994A5 (de) Grundlagen fuer aeusserlich anzuwendende arzneimittel.
DE2254061A1 (de) Lh-releasing hormon zur nasalen applikation
DE4018995A1 (de) Verfahren zur verbesserung der therapeutischen wirksamkeit von fettloeslichen kortikosteroiden und mittel zur anwendung dieses verfahrens
DE3022137C2 (xx)
DE3022136A1 (de) Verfahren zum abfuellen von bei raumtemperatur hochviskosen, phospholipide enthaltenden pharmazeutischen massen in hartkapseln
DE2838387A1 (de) Zusammensetzung zum fuellen von kapseln
DE2252637A1 (de) Choleretische arzneimittel
DE3526669C2 (xx)
DE69820608T2 (de) In gelatine eingekapselte sertarline dosierungsformen
AU643975B2 (en) Pharmaceutical formulation
CH627761A5 (en) Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone

Legal Events

Date Code Title Description
OD Request for examination
OHN Withdrawal